Literature DB >> 23666176

Neuropathologic correlates of cognition in a population-based sample.

Brenna Cholerton1, Eric B Larson, Laura D Baker, Suzanne Craft, Paul K Crane, Steven P Millard, Joshua A Sonnen, Thomas J Montine.   

Abstract

Many cognitively normal older adults have underlying neuropathologic changes of Alzheimer's disease (AD), vascular brain injury (VBI), or Lewy body disease (LBD), which confer an increased risk of dementia. The current study focused on the association between multiple neuropathologic indices and performance on specific cognitive domains in a community sample of older adults. Of 438 participants in the Adult Changes in Thought population-based study of brain aging who were autopsied, 363 subjects had cognitive testing at their final study visit and were included. Associations were measured between performance on the Cognitive Abilities Screening Instrument prior to death and neuropathologic endpoints, including AD neuropathologic changes, LBD, cerebral amyloid angiopathy, and measures of VBI. Braak stage for neurofibrillary tangles, lower brain weight, and VBI as measured by cerebral cortical microvascular lesions (μVBI) explained a significant proportion of the variance associated with global cognitive test performance (R2 = 0.31, p < 0.0001) both in the entire sample and when analysis was restricted to non-demented subjects (R2 = 0.23, p < 0.0001). Specific cognitive domains were differentially related to neuropathologic lesion type: memory and executive function with AD pathologic changes and cortical μVBI, executive function with subcortical μVBI, and visuospatial construction with LBD. Thus, neuropathologic lesions of LBD and μVBI are associated with poorer cognitive performance over and above AD neuropathologic changes in subjects without dementia in this cohort. These findings underscore that cognitive impairment is a complex convergent trait that has important implications for clinical investigation and medical management of older adults.

Entities:  

Mesh:

Year:  2013        PMID: 23666176      PMCID: PMC3737376          DOI: 10.3233/JAD-130281

Source DB:  PubMed          Journal:  J Alzheimers Dis        ISSN: 1387-2877            Impact factor:   4.472


  51 in total

1.  "Mini-mental state". A practical method for grading the cognitive state of patients for the clinician.

Authors:  M F Folstein; S E Folstein; P R McHugh
Journal:  J Psychiatr Res       Date:  1975-11       Impact factor: 4.791

2.  Neuropathological associates of multiple cognitive functions in two community-based cohorts of older adults.

Authors:  N Maritza Dowling; Sarah Tomaszewski Farias; Bruce R Reed; Joshua A Sonnen; Milton E Strauss; Julie A Schneider; David A Bennett; Dan Mungas
Journal:  J Int Neuropsychol Soc       Date:  2011-07       Impact factor: 2.892

3.  Cerebrovascular pathology and dementia in autopsied Honolulu-Asia Aging Study participants.

Authors:  Lon White; Helen Petrovitch; John Hardman; James Nelson; Daron G Davis; G Webster Ross; Kamal Masaki; Lenore Launer; William R Markesbery
Journal:  Ann N Y Acad Sci       Date:  2002-11       Impact factor: 5.691

4.  Dementia and Alzheimer disease incidence: a prospective cohort study.

Authors:  Walter A Kukull; Roger Higdon; James D Bowen; Wayne C McCormick; Linda Teri; Gerard D Schellenberg; Gerald van Belle; Lance Jolley; Eric B Larson
Journal:  Arch Neurol       Date:  2002-11

5.  A clinicopathological comparison of community-based and clinic-based cohorts of patients with dementia.

Authors:  F Massoud; G Devi; Y Stern; A Lawton; J E Goldman; Y Liu; S S Chin; R Mayeux
Journal:  Arch Neurol       Date:  1999-11

6.  Lewy body-related alpha-synucleinopathy in aging.

Authors:  Yuko Saito; Nyoka N Ruberu; Motoji Sawabe; Tomio Arai; Hirohito Kazama; Takayuki Hosoi; Hiroshi Yamanouchi; Shigeo Murayama
Journal:  J Neuropathol Exp Neurol       Date:  2004-07       Impact factor: 3.685

7.  Neuropathology of cognitively normal elderly.

Authors:  D S Knopman; J E Parisi; A Salviati; M Floriach-Robert; B F Boeve; R J Ivnik; G E Smith; D W Dickson; K A Johnson; L E Petersen; W C McDonald; H Braak; R C Petersen
Journal:  J Neuropathol Exp Neurol       Date:  2003-11       Impact factor: 3.685

8.  Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease.

Authors:  G McKhann; D Drachman; M Folstein; R Katzman; D Price; E M Stadlan
Journal:  Neurology       Date:  1984-07       Impact factor: 9.910

9.  Regional cerebral blood flow in Parkinson's disease with and without dementia.

Authors:  M J Firbank; S J Colloby; D J Burn; I G McKeith; J T O'Brien
Journal:  Neuroimage       Date:  2003-10       Impact factor: 6.556

Review 10.  Dementia with Lewy bodies.

Authors:  Ian McKeith; Jacobo Mintzer; Dag Aarsland; David Burn; Helen Chiu; Jiska Cohen-Mansfield; Dennis Dickson; Bruno Dubois; John E Duda; Howard Feldman; Serge Gauthier; Glenda Halliday; Brian Lawlor; Carol Lippa; Oscar L Lopez; João Carlos Machado; John O'Brien; Jeremy Playfer; Wayne Reid
Journal:  Lancet Neurol       Date:  2004-01       Impact factor: 44.182

View more
  24 in total

1.  Type 2 diabetes and later cognitive function in older American Indians: The Strong Heart Study.

Authors:  Brenna Cholerton; Adam Omidpanah; Steven P Verney; Lonnie A Nelson; Laura D Baker; Astrid Suchy-Dicey; William T Longstreth; Barbara V Howard; Jeffrey A Henderson; Thomas J Montine; Dedra Buchwald
Journal:  Int J Geriatr Psychiatry       Date:  2019-04-15       Impact factor: 3.485

2.  Effect of common neuropathologies on progression of late life cognitive impairment.

Authors:  Lei Yu; Patricia A Boyle; Sue Leurgans; Julie A Schneider; Richard J Kryscio; Robert S Wilson; David A Bennett
Journal:  Neurobiol Aging       Date:  2015-04-22       Impact factor: 4.673

3.  Perspective: time to tackle blood pressure.

Authors:  Walter J Koroshetz
Journal:  Nature       Date:  2014-06-26       Impact factor: 49.962

4.  Human Striatal Dopaminergic and Regional Serotonergic Synaptic Degeneration with Lewy Body Disease and Inheritance of APOE ε4.

Authors:  Nadia Postupna; Caitlin S Latimer; Eric B Larson; Emily Sherfield; Julie Paladin; Carol A Shively; Matthew J Jorgensen; Rachel N Andrews; Jay R Kaplan; Paul K Crane; Kathleen S Montine; Suzanne Craft; C Dirk Keene; Thomas J Montine
Journal:  Am J Pathol       Date:  2017-02-16       Impact factor: 4.307

5.  Long-Term Risk of Dementia Among Survivors of Ischemic or Hemorrhagic Stroke.

Authors:  Priscila Corraini; Victor W Henderson; Anne G Ording; Lars Pedersen; Erzsébet Horváth-Puhó; Henrik T Sørensen
Journal:  Stroke       Date:  2016-11-29       Impact factor: 7.914

6.  Antemortem Prediction of Braak Stage.

Authors:  Jesper O E Carlson; Margaret Gatz; Nancy L Pedersen; Caroline Graff; Inger Nennesmo; Anna-Karin Lindström; Lotte Gerritsen
Journal:  J Neuropathol Exp Neurol       Date:  2015-11       Impact factor: 3.685

7.  Application of the condensed protocol for the NIA-AA guidelines for the neuropathological assessment of Alzheimer's disease in an academic clinical practice.

Authors:  Rajnish Bharadwaj; Patrick J Cimino; Margaret E Flanagan; Caitlin S Latimer; Luis F Gonzalez-Cuyar; Gordana Juric-Sekhar; Thomas J Montine; Desiree A Marshall; C Dirk Keene
Journal:  Histopathology       Date:  2017-11-22       Impact factor: 5.087

8.  Editorial: Geriatrics in the 21st Century.

Authors:  B Vellas; J E Morley
Journal:  J Nutr Health Aging       Date:  2018       Impact factor: 4.075

Review 9.  Challenges of multimorbidity of the aging brain: a critical update.

Authors:  Kurt A Jellinger; Johannes Attems
Journal:  J Neural Transm (Vienna)       Date:  2014-08-05       Impact factor: 3.575

10.  Disentangling the effects of age and APOE on neuropathology and late life cognitive decline.

Authors:  Lei Yu; Patricia A Boyle; Sue Leurgans; Julie A Schneider; David A Bennett
Journal:  Neurobiol Aging       Date:  2013-10-09       Impact factor: 4.673

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.